Intratumoral macrophage phenotype and CD8+ T lymphocytes as potential tools to predict local tumor outgrowth at the intervention site in malignant pleural mesothelioma

Intratumoral macrophage phenotype and CD8+ T lymphocytes as potential tools to predict local tumor outgrowth at the intervention site in malignant pleural mesothelioma
复制标题

DOI:
10.1016/j.lungcan.2015.03.013
复制
发表时间:
2015-06-01
期刊:
影响因子:
5.3
通讯作者:
Aerts, Joachim G. J. V.
Aerts, Joachim G. J. V.
中科院分区:
医学2区
文献类型:
--
作者:
Cornelissen, Robin;Lieyense, Lysanne A.;Aerts, Joachim G. J. V.

文献摘要

被引文献

相似文献

目的:在恶性胸膜间皮瘤(MPM)患者中,侵入性手术后的局部肿瘤生长(LTO)是一种众所周知的并发症。目前,没有生物标志物可用于预测LTO的发生。本研究旨在探讨肿瘤巨噬细胞浸润和CD 8(+)T细胞的表型和/或浸润是否预测LTO.Materials和方法:10例发生LTO的间皮瘤患者与10例非LTO间皮瘤患者的临床和病理匹配。对诊断性活检进行免疫组化以确定总TAM(CD 68)、M2 TAM(CD 163)和CD 8(+)T细胞计数(CD 8)。结果:两组之间的平均M2/总TAM比率不同:LTO组为0.90 +/- 0.09,而非LTO患者为0.63 +/- 0.09(p < 0.001)。此外,两组之间的平均CD 8(+)T细胞计数存在显著差异:30/0.025 cm(2)(范围2-60)和140/0.025 cm(2)(范围23-314),无LTO的患者(p < 0.01)。这项研究表明,局部干预后发生LTO的患者具有较高的M2/总TAM比率和较低的CD 8(+)诊断时的细胞计数与未发生这种生长的患者相比。我们认为,M2/总TAM比值和CD 8(+)T细胞数量是预测MPM患者易于发生LTO的潜在工具。(C)2015爱思唯尔爱尔兰有限公司版权所有。
Objectives: In patients with malignant pleural mesothelioma (MPM), local tumor outgrowth (LTO) after invasive procedures is a well-known complication. Currently, no biomarker is available to predict the occurrence of LTO. This study aims to investigate whether the tumor macrophage infiltration and phenotype of and/or the infiltration of CD8(+) T-cells predicts LTO.Materials and methods: Ten mesothelioma patients who developed LTO were clinically and pathologically matched with 10 non-LTO mesothelioma patients. Immunohistochemistry was performed on diagnostic biopsies to determine the total TAM (CD68), the M2 TAM (CD163) and CD8(+) T-cell count (CD8).Results: The mean M2/total TAM ratio differed between the two groups: 0.90 +/- 0.09 in the LTO group versus 0.63 +/- 0.09 in patients without LTO (p < 0.001). In addition, the mean CD8(+) T-cell count was significantly different between the two groups: 30 per 0.025 cm(2) (range 2-60) in the LTO group and 140 per 0.025 cm(2) (range 23-314) in the patients without LTO (p < 0.01).Conclusion: This study shows that patients who develop LTO after a local intervention have a higher M2/total TAM ratio and lower CD8(+) cell count at diagnosis compared to patients who did not develop this outgrowth. We propose that the M2/total TAM ratio and the CD8(+) T-cell amount are potential tools to predict which MPM patients are prone to develop LTO. (C) 2015 Elsevier Ireland Ltd. All rights reserved.